TTD | Drug: D03AOP

Drug General Information
Drug ID	D03AOP
Former ID	DNCL003435
Drug Name	DS-8500
Indication	Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1]		Phase 2	[524885]
Company	Daiichi Sankyo
Target and Pathway
Target(s)	Glucose-dependent insulinotropic receptor	Target Info	Modulator	[544477]
KEGG Pathway	cAMP signaling pathway
KEGG Pathway	Insulin secretion
WikiPathways	Incretin Synthesis, Secretion, and Inactivation
References
Ref 524885	ClinicalTrials.gov (NCT02222350) Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes. U.S. National Institutes of Health.
Ref 544477	Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development. Curr Diabetes Rev. 2015 March; 11(1): 17-31.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information